Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Moroi, I."'
Autor:
Constantinescu, G., Ilie, M., Vasile Sandru, Moroi, I., Diaconu, I., Hortopan, A., Diaconu, C., Rînja, E.
Publikováno v:
Archives of the Balkan Medical Union, Vol 53, Iss 1, Pp 147-151 (2018)
Scopus-Elsevier
Scopus-Elsevier
Introduction. Esophageal dysphagia can be caused by functional or structural abnormalities of the esophagus like esophageal strictures due to acid reflux disease, eosinophilic esophagitis, tumors and extrinsic compression, or by neuromuscular disorde
Autor:
MARTIN, Anca Simina1 anca.martin@ulbsibiu.ro
Publikováno v:
Revista Transilvania. 2023, Issue 7, p17-25. 9p.
Autor:
Banach, Maciej, Surma, Stanisław, Kapłon-Cieślicka, Agnieszka, Mitkowski, Przemysław, Dzida, Grzegorz, Tomasik, Tomasz, Mastalerz-Migas, Agnieszka
Publikováno v:
General Practitioner / Lekarz POZ; 2023, Vol. 9 Issue 6, p309-326, 18p
Publikováno v:
Paliatia: Journal of Palliative Care. Apr2019, Vol. 12 Issue 2, p9-14. 6p.
Autor:
Ştefani, Constantin1, Veronica Grăjdeanu, Ioana1, Şerban, Bogdan1,2, Alexandra Stănescu, Ana Maria1 alexandrazotta@yahoo.com
Publikováno v:
Romanian Medical Journal. 2019, Vol. 66 Issue 1, p24-28. 5p.
Autor:
HULUBAŞ, ADINA1
Publikováno v:
Memoria Ethnologica. jul-dec2013, Vol. 13 Issue 48/49, p56-71. 16p.
Autor:
Yeung, Jennifer, Adili, Reheman, Stringham, Emily N., Luo, Rong, Vizurraga, Alexander, Rosselli-Murai, Luciana K., Stoveken, Hannah M., Maiya Yu, Xianhua Piao, Holinstat, Michael, Tall, Gregory G.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; 11/10/2020, Vol. 117 Issue 45, p28275-28286, 12p
Publikováno v:
Journal of High Energy Physics; Dec2019, Vol. 2019 Issue 12, p1-29, 29p
Autor:
Cagide, Eva, Louzao, M. Carmen, Espiña, Begoña, Vieytes, Mercedes R., Jaen, David, Maman, Luz, Yasumoto, Takeshi, Botana, Luis M.
Publikováno v:
Cellular Physiology & Biochemistry (Karger AG); 2009, Vol. 23 Issue 4-6, p431-440, 10p, 1 Chart, 7 Graphs
Publikováno v:
Annals of Oncology. 25:iv379
Aim: We report updated survival and clinical activity of nivolumab, a fully human IgG4 programmed cell death-1 (PD-1) immune checkpoint inhibitor antibody, in a phase 2 study (ONO-4538-02) of previously treated Japanese patients (pts) with advanced m